Area of research
Genetics · Hematology
Research interest
Research interests include Mesenchymal stem cell research, Hematopoietic Stem Cell Transplantation, Tissue Engineering and Regenerative Medicine, and Neonatal Respiratory Health Research.
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes
Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
MSCs—cells with many sides
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Mesenchymal stromal cells and the innate immune response
Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles
In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
Stromal cell–mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade <scp>III</scp>–<scp>IV</scp> acute graft‐versus‐host disease
Pre- and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two-Center Experience
Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation
Multipotent mesenchymal stromal cells and the innate immune system
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation